s6y
Company name or ticker
Search
Poulton Jeffrey V.
3
ALNYLAM PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
Filed
Tuesday, August 13, 2019
Period
Aug 13, 2019
Accession number
0001735276-19-000089
Documents
PRIMARY DOCUMENT
3
EDGAR SUPPORTING DOCUMENT
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header